Cell Stress and Chaperones

, Volume 23, Issue 4, pp 551–560 | Cite as

Tauroursodeoxycholic acid alleviates secondary injury in the spinal cord via up-regulation of CIBZ gene

  • Zongmeng Zhang
  • Jie Chen
  • Fanghui Chen
  • Daolun Yu
  • Rui Li
  • Chenglong Lv
  • Haosen Wang
  • Honglin Li
  • Jun LiEmail author
  • Yafei CaiEmail author
Original Paper


Spinal cord injury (SCI) is generally divided into primary and secondary injuries, and apoptosis is an important event of the secondary injury. As an endogenous bile acid and recognized endoplasmic reticulum (ER) stress inhibitor, tauroursodeoxycholic acid (TUDCA) administration has been reported to have a potentially therapeutic effect on neurodegenerative diseases, but its real mechanism is still unclear. In this study, we evaluated whether TUDCA could alleviate traumatic damage of the spinal cord and improve locomotion function in a mouse model of SCI. Traumatic SCI mice were intraperitoneally injected with TUDCA, and the effects were evaluated based on motor function assessment, histopathology, apoptosis detection, qRT-PCR, and western blot at different time periods. TUDCA administration can improve motor function and reduce secondary injury and lesion area after SCI. Furthermore, the apoptotic ratios were significantly reduced; Grp78, Erdj4, and CHOP were attenuated by the treatment. Unexpectedly, the levels of CIBZ, a novel therapeutic target for SCI, were specifically up-regulated. Taken together, it is suggested that TUDCA effectively suppressed ER stress through targeted up-regulation of CIBZ. This study also provides a new strategy for relieving secondary damage by inhibiting apoptosis in the early treatment of spinal cord injury.


Tauroursodeoxycholic acid Spinal cord injury ER stress Apoptosis CIBZ 


Funding information

This study was supported by the National Natural Science Foundation of China (NSFC, 31372207 and 81570094), the Innovation Team of Scientific Research Platform in Anhui Province, a start-up grant from Nanjing Agricultural University (804090), and the “Sanxin” Research Program of Jiangsu Province (SXGC[2016]312).

Compliance with ethical standards

All animal experiments complied with the ARRIVE guidelines and were carried out according to the National Institutes of Health guide for the care and use of laboratory animals. All animal experiments were approved by the Anhui Normal University Academic Ethics Committee.


  1. Ahn YH, Lee G, Kang SK (2006) Molecular insights of the injured lesions of rat spinal cords: inflammation, apoptosis, and cell survival. Biochem Biophys Res Commun 348:560–570. CrossRefPubMedGoogle Scholar
  2. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG (2006) Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 23:635–659. CrossRefPubMedGoogle Scholar
  3. Boyce M, Yuan J (2006) Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ 13:363–373. CrossRefPubMedGoogle Scholar
  4. Cai Y, Fan R, Hua T, Liu H, Li J (2011) Nimodipine alleviates apoptosis-mediated impairments through the mitochondrial pathway after spinal cord injury. Curr Zool 57:340–349CrossRefGoogle Scholar
  5. Cai Y, Li J, Yang S, Li P, Zhang X, Liu H (2012) CIBZ, a novel BTB domain-containing protein, is involved in mouse spinal cord injury via mitochondrial pathway independent of p53 gene. PLoS One 7:e33156. CrossRefPubMedPubMedCentralGoogle Scholar
  6. Cai Y, Li J, Zhang Z, Chen J, Zhu Y, Li R, Chen J, Gao L, Liu R, Teng Y (2017) Zbtb38 is a novel target for spinal cord injury. Oncotarget 8:45356–45366.  10.18632/oncotarget.17487 PubMedPubMedCentralCrossRefGoogle Scholar
  7. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS (1997) Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3:73–76CrossRefPubMedGoogle Scholar
  8. Furlan JC, Fehlings MG (2008) Cardiovascular complications after acute spinal cord injury: pathophysiology, diagnosis, and management. Neurosurg Focus 25:E13. CrossRefPubMedGoogle Scholar
  9. Keene CD, Rodrigues CM, Eich T, Chhabra MS, Steer CJ, Low WC (2002) Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington’s disease. Proc Natl Acad Sci U S A 99:10671–10676. CrossRefPubMedPubMedCentralGoogle Scholar
  10. Kotaka K, Nagai J, Hensley K, Ohshima T (2017) Lanthionine ketimine ester promotes locomotor recovery after spinal cord injury by reducing neuroinflammation and promoting axon growth. Biochem Biophys Res Commun 483:759–764. CrossRefPubMedGoogle Scholar
  11. Kurisu J, Honma A, Miyajima H, Kondo S, Okumura M, Imaizumi K (2003) MDG1/ERdj4, an ER-resident DnaJ family member, suppresses cell death induced by ER stress. Genes Cells 8:189–202CrossRefPubMedGoogle Scholar
  12. Lee YY, Hong SH, Lee YJ, Chung SS, Jung HS, Park SG, Park KS (2010) Tauroursodeoxycholate (TUDCA), chemical chaperone, enhances function of islets by reducing ER stress. Biochem Biophys Res Commun 397:735–739. CrossRefPubMedGoogle Scholar
  13. Lu J, Ashwell KW, Waite P (2000) Advances in secondary spinal cord injury: role of apoptosis. Spine 25:1859–1866CrossRefPubMedGoogle Scholar
  14. McDonald JW, Sadowsky C (2002) Spinal-cord injury. Lancet 359:417–425. CrossRefPubMedGoogle Scholar
  15. Nishii T, Oikawa Y, Ishida Y, Kawaichi M, Matsuda E (2012) CtBP-interacting BTB zinc finger protein (CIBZ) promotes proliferation and G1/S transition in embryonic stem cells via Nanog. J Biol Chem 287:12417–12424. CrossRefPubMedPubMedCentralGoogle Scholar
  16. Noreau L, Proulx P, Gagnon L, Drolet M, Laramee MT (2000) Secondary impairments after spinal cord injury: a population-based study. Am J Phys Med Rehabil 79:526–535CrossRefPubMedGoogle Scholar
  17. Ohri SS, Maddie MA, Zhao Y, Qiu MS, Hetman M, Whittemore SR (2011) Attenuating the endoplasmic reticulum stress response improves functional recovery after spinal cord injury. Glia 59:1489–1502CrossRefPubMedPubMedCentralGoogle Scholar
  18. Oikawa Y, Matsuda E, Nishii T, Ishida Y, Kawaichi M (2008) Down-regulation of CIBZ, a novel substrate of caspase-3, induces apoptosis. J Biol Chem 283:14242–14247. CrossRefPubMedGoogle Scholar
  19. Penas C, Guzman MS, Verdu E, Fores J, Navarro X, Casas C (2007) Spinal cord injury induces endoplasmic reticulum stress with different cell-type dependent response. J Neurochem 102:1242–1255. CrossRefPubMedGoogle Scholar
  20. Podda M, Crosignani A, Battezzati P, Buscarini L, Conte D, Notarbartolo A, Floreani A, Stabilini R, Manghisi OG (1995) Tauroursodeoxycholic acid for the treatment of chronic hepatitis: a dose-response study. Hepatology 22:A120CrossRefGoogle Scholar
  21. Ramalho RM, Ribeiro PS, Sola S, Castro RE, Steer CJ, Rodrigues CM (2004) Inhibition of the E2F-1/p53/Bax pathway by tauroursodeoxycholic acid in amyloid beta-peptide-induced apoptosis of PC12 cells. J Neurochem 90:567–575. CrossRefPubMedGoogle Scholar
  22. Ramalho RM, Viana RJ, Low WC, Steer CJ, Rodrigues CM (2008) Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer’s disease. Trends Mol Med 14:54–62. CrossRefPubMedGoogle Scholar
  23. Rodrigues CM, Sola S, Nan Z, Castro RE, Ribeiro PS, Low WC, Steer CJ (2003) Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc Natl Acad Sci U S A 100:6087–6092. CrossRefPubMedPubMedCentralGoogle Scholar
  24. Romero-Ramirez L, Nieto-Sampedro M, Yanguas-Casas N (2017) Tauroursodeoxycholic acid: more than just a neuroprotective bile conjugate. Neural Regen Res 12:62–63. CrossRefPubMedPubMedCentralGoogle Scholar
  25. Schroeder GD, Kepler CK, Vaccaro AR (2016) The use of cell transplantation in spinal cord injuries. J Am Acad Orthop Surg 24:266–275. CrossRefPubMedGoogle Scholar
  26. Shuda M, Kondoh N, Imazeki N, Tanaka K, Okada T, Mori K, Hada A, Arai M, Wakatsuki T, Matsubara O, Yamamoto N, Yamamoto M (2003) Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol 38:605–614CrossRefPubMedGoogle Scholar
  27. Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7:880–885. CrossRefPubMedPubMedCentralGoogle Scholar
  28. Takayanagi S, Fukuda R, Takeuchi Y, Tsukada S, Yoshida K (2013) Gene regulatory network of unfolded protein response genes in endoplasmic reticulum stress. Cell Stress Chaperones 18:11–23. CrossRefPubMedGoogle Scholar
  29. Vang S, Longley K, Steer CJ, Low WC (2014) The unexpected uses of urso- and tauroursodeoxycholic acid in the treatment of non-liver diseases. Glob Adv Health Med 3:58–69. CrossRefPubMedPubMedCentralGoogle Scholar
  30. Wang M, Wang P, Peng JL, Wu S, Zhao XP, Li L, Shen GX (2009) The altered expression of glucose-regulated proteins 78 in different phase of streptozotocin-affected pancreatic beta-cells. Cell Stress Chaperones 14:43–48. CrossRefPubMedGoogle Scholar
  31. Wang Z, Zhang C, Hong Z, Chen H, Chen W, Chen G (2013) C/EBP homologous protein (CHOP) mediates neuronal apoptosis in rats with spinal cord injury. Exp Ther Med 5:107–111. CrossRefPubMedGoogle Scholar
  32. Wang C, Liu C, Gao K, Zhao H, Zhou Z, Shen Z, Guo Y, Li Z, Yao T, Mei X (2016) Metformin preconditioning provide neuroprotection through enhancement of autophagy and suppression of inflammation and apoptosis after spinal cord injury. Biochem Biophys Res Commun 477:534–540. CrossRefPubMedGoogle Scholar
  33. Wells JE, Hurlbert RJ, Fehlings MG, Yong VW (2003) Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126:1628CrossRefPubMedGoogle Scholar
  34. Xie Q, Khaoustov VI, Chung CC, Sohn J, Krishnan B, Lewis DE, Yoffe B (2002) Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology 36:592–601. CrossRefPubMedGoogle Scholar
  35. Xu C, Bailly-Maitre B, Reed JC (2005) Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 115:2656–2664. CrossRefPubMedPubMedCentralGoogle Scholar
  36. Yanguas-Casas N, Barreda-Manso MA, Nieto-Sampedro M, Romero-Ramirez L (2014) Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation. J Neuroinflammation 11:50. CrossRefPubMedPubMedCentralGoogle Scholar
  37. Yanguas-Casas N, Barreda-Manso MA, Perez-Rial S, Nieto-Sampedro M, Romero-Ramirez L (2016) TGFbeta contributes to the anti-inflammatory effects of tauroursodeoxycholic acid on an animal model of acute neuroinflammation. Mol Neurobiol.
  38. Yin X, Yin Y, Cao FL, Chen YF, Peng Y, Hou WG, Sun SK, Luo ZJ (2012) Tanshinone IIA attenuates the inflammatory response and apoptosis after traumatic injury of the spinal cord in adult rats. PLoS One 7:e38381. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Cell Stress Society International 2017

Authors and Affiliations

  • Zongmeng Zhang
    • 1
  • Jie Chen
    • 1
    • 2
  • Fanghui Chen
    • 3
  • Daolun Yu
    • 1
  • Rui Li
    • 1
  • Chenglong Lv
    • 3
  • Haosen Wang
    • 4
  • Honglin Li
    • 5
  • Jun Li
    • 1
    Email author
  • Yafei Cai
    • 3
    Email author
  1. 1.College of Life Sciences, The Provincial Key Lab of the Conservation and Exploitation Research of Biological Resources in AnhuiAnhui Normal UniversityWuhuChina
  2. 2.The Secondary Hospital of WuhuWuhuChina
  3. 3.College of Animal Science and TechnologyNanjing Agricultural UniversityNanjingChina
  4. 4.The Forth Hospital of TaizhouTaizhouChina
  5. 5.Department of Biochemistry and Molecular BiologyAugusta UniversityAugustaUSA

Personalised recommendations